Research Topics
| Francesca BagnatoSummaryAffiliation: Vanderbilt University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Visualizing iron in multiple sclerosisFrancesca Bagnato
Radiology Department, Vanderbilt University, Institute of Imaging Science, Nashville, TN 37232, USA
Magn Reson Imaging 31:376-84. 2013....
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosisZ Campbell
Neuroimmunology Branch NIB, NIH, Bethesda, MD, USA
Neurology 78:1493-9. 2012....
Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced diseaseFrancesca Bagnato
National Institutes of Neurological Disorders and Stroke, Building 10, Room C103, NIH, Bethesda, MD, USA
Mult Scler 17:1424-31. 2011....
Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple SclerosisNieves Velez de Mendizabal
Division of Neurosciences, CIMA University of Navarra, Avenida Pio XII 55, 31008 Pamplona, Spain
BMC Syst Biol 5:114. 2011..g. failure in central tolerance, activation by pathogens) that are able to trigger the immune system...
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 TeslaFrancesca Bagnato
National Institutes of Neurological Disorders and Stroke NINDS, National Institutes of Health, Bethesda, MD, USA
Brain 134:3602-15. 2011..Iron identification by multi-gradient echo magnetic resonance imaging in diseased tissues can shed light on the pathological processes when coupled with topographical information and patient disease history...
Painful and involuntary multiple sclerosisFrancesca Bagnato
Vanderbilt University Institute of Imaging Science 1161 21st Ave S AA1105 MCN Radiology Department, Nashville, TN 37232, USA
Expert Opin Pharmacother 12:763-77. 2011..EXPERT OPINION: To effectively manage MS, it is essential that these symptoms are recognized as early as possible and treated by a rehabilitative multidisciplinary approach, based on proven scientific evidence...
T1 cortical hypointensities and their association with cognitive disability in multiple sclerosisFrancesca Bagnato
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1400, USA
Mult Scler 16:1203-12. 2010..Neocortical lesions (NLs) largely contribute to the pathology of multiple sclerosis (MS), although their relevance in patients' disability remains unknown...
Relationship of cortical atrophy to fatigue in patients with multiple sclerosisClelia Pellicano
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bethesda, MD 20892 1400, USA
Arch Neurol 67:447-53. 2010..Fatigue is a common and disabling symptom of multiple sclerosis (MS). Previous studies reported that damage of the corticostriatothalamocortical circuit is critical in its occurrence...
Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosisGiuseppe Bomboi
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892 1400, USA
J Neuroimaging 21:e57-63. 2011....
Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging studyAnnie W Chiu
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 1400, USA
Arch Neurol 66:39-43. 2009..To investigate the heterogeneity in magnetic resonance image (MRI) patterns of response to interferon beta across patients with multiple sclerosis or within an individual patient over time...
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, 10 Center Drive, Bethesda, Maryland 20892, USA
Expert Opin Biol Ther 8:1823-9. 2008..IFN-beta-1b decreases the formation of CELs. However, the ability of IFN-beta-1b to reduce the size of CELs arising during therapy has not been extensively investigated...
Chronic multiple sclerosis lesions: characterization with high-field-strength MR imagingBing Yao
Advanced MRI Section, Laboratory of Functional Molecular Imaging, and Neuroimmunology Branch, Neurologic Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bldg 10, Bethesda, MD 20892 1065, USA
Radiology 262:206-15. 2012....
Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging studyFrancesca Bagnato
Neuroimmunology Branch NIB, National Institute of Neurological Disorders and Stroke NINDS, NIH, Bethesda, MD 20892 1400, USA
J Neurol Sci 282:80-5. 2009....
The effect of interferon-beta on black holes in patients with multiple sclerosisFrancesca Bagnato
National Institute of Health, National Institute for Neurological Diseases and Stroke, Neuroimmunology Branch, Bethesda, MD 20892 1400, USA
Expert Opin Biol Ther 7:1079-91. 2007..However, whether the effect of IFN-beta extends beyond just prevention of blood-brain barrier leakage and further prevents the formation of black holes or promotes their recovery once formed, is not yet understood...
Neutralising antibodies to IFN-beta in patients with multiple sclerosisFrancesca Bagnato
National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch, NIH, 10 Center Drive, Building 10, Room 5B16, Bethesda, MD, 20892 1400 MSC, USA
Expert Opin Biol Ther 6:773-85. 2006..In particular, the effects of NABs in reducing the efficacy of IFN-beta therapy beyond clinical relapse rate and lesion load on conventional imaging are not as yet fully understood...
Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosisFrancesca Bagnato
Neuroimmunology Branch, NIND NIH, 10 Center Drive, Building 10, Room 5B16, Bethesda, MD 20892 1400, USA
Expert Rev Neurother 6:599-612. 2006..The appropriate use of the above-mentioned techniques has the potential to more accurately explain the level of disability in MS patients...
